Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Cardiovascular Sweden AB
AB
Active
Org 5568145147
S:T Johannesgatan 3 A, 211 46
Malmö
Engineering activities and related technical consultancy
· NACE 7112
Est. 2010
0 employees
Watchlist
Share
Sweden
/
Companies
/
Engineering activities and related technical consultancy
/
Cardiovascular Sweden AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
1M
2024
1M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
1M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
68
382
214
931
656
Staff expenses
—
—
−21
−2
−29
EBITDA
−46
260
93
776
471
Depreciation & amort.
−0
−0
—
—
—
EBIT
−46
260
93
776
471
Net financials
64
−11
3
10
18
Profit before tax
13
206
70
576
389
Tax
−4
−49
−17
−130
−94
Net profit
9
157
53
446
294
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
580
825
936
1 712
2 046
Equity
296
453
506
952
1 246
Long-term debt
0
0
—
—
—
Short-term debt
199
238
269
389
329
Total debt
199
238
269
389
329
Financial ratios
5-year trend
EBITDA margin
71.8%
This company
15.8%
Market median
+354% vs market
2021
2025
Equity ratio
60.9%
This company
38.2%
Market median
+59% vs market
2021
2025
Return on equity
23.6%
This company
18.4%
Market median
+28% vs market
2021
2025
Net profit margin
44.9%
This company
8.1%
Market median
+454% vs market
2021
2025
Asset turnover
0.32×
This company
1.12×
Market median
-71% vs market
2021
2025
Debt / equity
0.64×
This company
0.62×
Market median
+3% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
View
PDF
More on Cardiovascular Sweden AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network